Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
Japan · Delayed Price · Currency is JPY 2,388.50
-95.00 (-3.83%)
Jul 31, 2026, 3:30 PM JST
Rohto Pharmaceutical Market Cap
Rohto Pharmaceutical has a market cap or net worth of 539.72 billion as of July 31, 2026. Its market cap has increased by 11.09% in one year.
Market Cap
539.72B
Enterprise Value
531.49B
Revenue
343.73B
Ranking
n/a
PE Ratio
16.44
Stock Price
2,388.50
ChartMarket Cap Chart
Since July 4, 1997, Rohto Pharmaceutical's market cap has increased from 64.95B to 539.72B, an increase of 731.02%. That is a compound annual growth rate of 7.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 539.72B | -9.11% |
| Dec 30, 2025 | 593.83B | -9.54% |
| Dec 30, 2024 | 656.47B | 1.21% |
| Dec 29, 2023 | 648.60B | 22.54% |
| Dec 30, 2022 | 529.28B | 33.52% |
| Dec 30, 2021 | 396.39B | 13.75% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicharm | 1.73T |
| Shiseido Company | 1.34T |
| Lion Corporation | 472.55B |
| Kobayashi Pharmaceutical | 426.33B |
| Paltac | 401.59B |
| KOSE Holdings | 322.55B |
| Pola Orbis Holdings | 309.57B |
| MTG Co., Ltd. | 282.58B |